Loading...
Market
What leadership changes will occur at the Brisbane Virology Lab by June 30, 2025 following the breach?
2
Resolution / Starting Odds
Director replaced • 25%
Management restructuring • 25%
No changes • 25%
Other changes • 25%
Official announcements regarding leadership changes in the lab
Story
Australia Investigates Major Biosecurity Breach After 323 Deadly Virus Samples Go Missing from Brisbane Lab
Dec 10, 2024, 08:37 PM
An independent investigation has been launched after 323 vials containing live viruses went missing from the Virology Laboratory in Brisbane, Australia. The missing samples include Hendra virus, Lyssavirus, and Hantavirus, with nearly 100 live samples of the deadly Hendra virus unaccounted for. Queensland Health Minister Tim Nicholls announced the major breach of biosecurity protocols, emphasizing that "there is nothing to suggest that these have been taken from the laboratory." The vials are believed to have gone missing in 2021, but the loss was only discovered in 2023 during a routine audit. Authorities are investigating the breach to determine how it occurred and to prevent future incidents.
View original story
Similar markets
New regulations • 25%
Increased funding for lab security • 25%
No significant action • 25%
Other • 25%
Yes • 50%
No • 50%
Human error identified • 25%
Security breach • 25%
Procedural lapse • 25%
Other • 25%
High concern • 25%
Moderate concern • 25%
Low concern • 25%
No concern • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
New Director-General Appointed • 25%
Interim Leadership • 25%
No Change in Leadership • 25%
Other Leadership Change • 25%
Commissioner replaced • 25%
Senior officials replaced • 25%
No changes • 25%
Other • 25%
Kash Patel Appointed • 25%
Christopher Wray Retained • 25%
New Nominee Announced • 25%
No Change Announced • 25%
Increase in NIH funding for non-pharmaceutical research • 25%
Reduction in NIH collaborations with pharmaceutical companies • 25%
No significant changes in NIH leadership or policy • 25%
Other significant leadership changes • 25%
Yes • 50%
No • 50%
Leadership change at CDC • 25%
Leadership change at FDA • 25%
Leadership change at HHS • 25%
No leadership changes • 25%